Circulating tumor cells and evaluation of targeted therapy effect in EGFR mutation/ALK translocation metastatic non-small cell lung cancer.

被引：0
|
作者：
Su, ChunXia
Li, Xuefei
Ren, Shengxiang
Gao, Guanghui
Li, Wei
Zhao, Jing
Chen, Xiaoxia
Zhao, Chao
Zhou, Caicun
机构：
[1] Shanghai Pulm Hosp, Dept Oncol, Shanghai, Peoples R China
[2] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China
[3] Tongji Univ, Sch Med, Inst Canc, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
[4] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
[5] Tongji Univ, Dept Med Oncol, Affiliated Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
[6] Tongji Univ, Sch Med, Inst Canc, Dept Oncol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
[7] Tongji Univ, Sch Med, Inst Canc, Dept Med Oncol,Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
[8] Tongji Univ, Shanghai Pulm Hosp, Dept Oncol, Shanghai 200092, Peoples R China
[9] Tongji Univ, Sch Med, Inst Canc, Shanghai 200092, Peoples R China
[10] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Dept Lung Canc & Immunol, Shanghai 200092, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19084
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A study of EGFR wild-type non-small cell lung cancer ALK genetic mutation
    Wang, Shoufeng
    Mao, Naiquan
    Zuo, Chuantian
    Pan, Hong
    Xie, Tong
    Huang, Yaoyuan
    Pan, Qi
    Wu, Junwei
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 (05) : 976 - 980
  • [32] Does EGFR and ALK Mutation Status Correlate With Tumour Morphology in Non-Small Cell Lung Cancer?
    Waise, S.
    Jogai, S.
    JOURNAL OF PATHOLOGY, 2015, 237 : S23 - S23
  • [33] Circulating Tumor DNA Is Effective for the Detection of EGFR Mutation in Non-Small Cell Lung Cancer: A Meta-analysis
    Qiu, Mantang
    Wang, Jie
    Xu, Youtao
    Ding, Xiangxiang
    Li, Ming
    Jiang, Feng
    Xu, Lin
    Yin, Rong
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2015, 24 (01) : 206 - 212
  • [34] Metabolic approach to EGFR-targeted therapy in non-small cell lung cancer
    Kam, Yoonseok
    Swain, Pamela
    Romero, Natalia
    Dranka, Brian P.
    CANCER RESEARCH, 2019, 79 (13)
  • [35] EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
    Reade, Chad A.
    Ganti, Apar Kishor
    BIOLOGICS-TARGETS & THERAPY, 2009, 3 : 215 - 224
  • [36] Targeted Therapies in Non-Small Cell Lung Cance-rBeyond EGFR and ALK
    Rothschild, Sacha I.
    CANCERS, 2015, 7 (02) : 930 - 949
  • [37] Circulating Tumor Cells as a Risk Factor for Non-Small Cell Lung Cancer Treated with EGFR-TKI
    Liu, Yue
    Fan, Congying
    Hu, Haiyan
    Yang, Yaowen
    Yan, Shuning
    Gu, Yuelan
    Ding, Meng
    Li, Pengfei
    Wang, Yanling
    Wang, Hongyan
    Yang, Qie
    INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2022, 18 (02) : 199 - 206
  • [38] Characteristics Of Metastatic Brain Tumors From Non-Small Cell Lung Cancer With EGFR Mutation
    Sekine, A.
    Enomoto, Y.
    Oda, T.
    Kato, T.
    Hagiwara, E.
    Ogura, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [39] Association of allele frequency of EGFR mutation with efficacy of EGFR TKIs in advanced non-small cell lung cancer.
    Li, Xiang-Meng
    Yang, Jin-Ji
    Wu, Long
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [40] Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer
    Kim, Jeong-Oh
    Shin, Jung-Young
    Kim, Seo Ree
    Shin, Kab Soo
    Kim, Joori
    Kim, Min-Young
    Lee, Mi-Ran
    Kim, Yonggoo
    Kim, Myungshin
    Hong, Sook Hee
    Kang, Jin Hyoung
    CANCERS, 2020, 12 (04)
12345